Please provide your email address to receive an email when new articles are posted on . Researchers used data from the GRIPHON study and open-label extension study. The median selexipag dose was 1,000 ...

Patients with IPF and emphysema who received antifibrotic agents had similar outcomes to patients with IPF alone.

The REVEAL scores were superior to the ESC/ERS risk 2022 score and the COMPERA registry 3-strata risk score in predicting PH survival. Risk stratification scoring systems designed for pulmonary ...

In patients with pulmonary arterial hypertension (PAH), the use of anticoagulants was not associated with improvement in overall survival, and these results were confirmed by an updated meta-analysis.

(HealthDay News) — For patients undergoing right heart catheterization (RHC), borderline pulmonary hypertension (PH) is associated with increased risk of mortality, according to a study published ...

Dr. Sathish Kumar Krishnan has spent years tackling a silent crisis in healthcare: pulmonary hypertension (PH), a condition that affects thousands but remains underdiagnosed and under-treated. As a ...

Social inequalities significantly impact COPD and PH outcomes, highlighting the need for systemic health care solutions, emphasizes Lucilla Piccari, MD, PhD, Hospital del Mar. At the European ...

Please provide your email address to receive an email when new articles are posted on . Pulmonary hypertension appears in 25% to 30% of patients with COPD. There are no approved therapies for patients ...